Biochem antibiotics suscep testing
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- W81K0218D0007
- Awardee
-
Namu Med UEI FKMJKCM6K5A3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Task orders
- 5 $424,492 obligated
Award facts
- Opportunity
-
- W81K0218R0008 Solicitation number
- Biochemical Antibiotics Susceptibility Testings Award Notice · Posted Jun 12, 2018
- Combined order value
- $424,492 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 66% used
- $642,457.73
- Maximum order
- $643,694.31
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Namu Med Sales Division is providing biochemical antibiotics susceptibility testing reagents under an indefinite delivery contract with the Department of the Army Medical Command. The single award IDV facilitates delivery orders for reagents through September 2022, with a potential value of $642,457. Performance will take place in South Korea. No set asides were applied to the IDV or subsequent delivery orders.
Under the IDV, Namu Med has received five delivery orders totaling $394,735 to supply testing reagents to Army medical facilities in South Korea. Delivery orders were issued annually from 2018 through 2022 via firm fixed price contracts. The reagents support microbiological and antibiotic resistance testing at Brian Allgood Army Community Hospital and other DoD labs, enabling diagnostic capabilities for military personnel stationed abroad.
The IDV and delivery order mechanism allows the Army Medical Command to efficiently obtain specialized testing supplies on an as-needed basis from the prime contractor, Namu Med Sales Division. The reagents facilitate antibiotic susceptibility minimum guarantee testing and Biofire Filmarray instrument testing at overseas DoD medical labs through September 2022.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Biochem antibiotics suscep testing | Medical Command (Army) | $45,000 | |
| Biochem antibiotics suscep testing | Medical Command (Army) | $120,000 | |
| Biochem antibiotics suscep testing; exercise option II | Medical Command (Army) | $114,972 | |
| Biochem antibiotics suscep testing | Medical Command (Army) | $114,863 | |
| Biochem antibiotics suscep testing | Medical Command (Army) | $29,657 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81K0218D0007?
W81K0218D0007 was awarded to Namu Med by Medical Command (Department of the Army) on August 1, 2018.
How much is contract W81K0218D0007 worth?
Orders under W81K0218D0007 have obligated $424,492. W81K0218D0007's own ceiling is $642,458. A single order can be worth up to $643,694.
How many orders have been placed under contract W81K0218D0007?
5 orders have been placed under W81K0218D0007, the latest on October 1, 2021.
Who can order from contract W81K0218D0007?
W81K0218D0007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81K0218D0007 competed?
The extent of competition for W81K0218D0007 was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV